Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
Heart failure (HF), with steadily increasing incidence rates and mortality in an ageing population, represents a major challenge. Evidence suggests that more than half of all patients with a diagnosis of HF suffer from HF with preserved ejection fraction (HFpEF). Emerging novel biomarkers to improve...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Radcliffe Medical Media
2020-03-01
|
| סדרה: | Cardiac Failure Review |
| גישה מקוונת: | https://www.cfrjournal.com/articleindex/cfr.2019.10 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|